PE  Soleus Capital

http://soleuscapital.com/




     Office Locations:

104 Field Point Rd, 2nd Floor
Greenwich, CT 06830
Phone: 475-208-3178
 

Stages:

  • Middle Market
 

Industries:

  • Life Sciences & Healthcare


    		•
     

    Description:

    Soleus Capital Management is a private equity firm focused on investing within the healthcare sector. According to an SEC filing, the firm recently raised $39.55 million for its debut private equity fund. The target amount is $125 million.


     

    Funds:


      Fund Name
      Amount
      Date
    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)    		No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)    		$2M-$7M
    Expansion Stage
    (also called Late-stage)    		$7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Guy Bezalel Levy CIO
    Lennox Ketner Managing Director
    Steven Joseph Musumeci J.D. CCO
    Zachary Williams Analyst

     

    Recent Funding Events (trailing 12 months):


      Date
      Name
      State
      Amount
      Stage

      12/14/2023
      Parse Biosciences
      WA
      $50,000,000
      Series C

     

    Portfolio companies include:

     

    Recent News: